Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × 1 year × Clear all

Phase

Status

Recruiting 7 Completed 3 Suspended 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Specimen Handling 70 Carboplatin 67 Bevacizumab 65 Cisplatin 64 Drug Therapy 63 Cyclophosphamide 57 Capecitabine 56 Oxaliplatin 55 Magnetic Resonance Spectroscopy 55 pembrolizumab 53 Radiotherapy 52 Gemcitabine 49 Paclitaxel 45 tislelizumab 43 toripalimab 42 Standard of Care 40 Injections 36 Fluorouracil 36 Biopsy 35 fludarabine 33 Immune Checkpoint Inhibitors 33 Docetaxel 31 venetoclax 30 Nivolumab 30 lenvatinib 28 Surgical Procedures, Operative 28 Leucovorin 27 Irinotecan 27 Blood Specimen Collection 26 130-nm albumin-bound paclitaxel 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡